Cargando…

A follow-up study on Guillain-Barre syndrome and validation of Brighton criteria

Background: Guillain-Barre syndrome (GBS) is the major cause of acute flaccid paralysis (AFP). Comprehensive classification and predictive measures need to be created for GBS. This study was conducted to evaluate GBS patients’ prognosis and Brighton criteria validity in Iranian population. Methods:...

Descripción completa

Detalles Bibliográficos
Autores principales: Boostani, Reza, Ramezanzadeh, Farveh, Saeidi, Morteza, Khodabandeh, Mina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Tehran University of Medical Sciences 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6755501/
https://www.ncbi.nlm.nih.gov/pubmed/31565202
_version_ 1783453244252487680
author Boostani, Reza
Ramezanzadeh, Farveh
Saeidi, Morteza
Khodabandeh, Mina
author_facet Boostani, Reza
Ramezanzadeh, Farveh
Saeidi, Morteza
Khodabandeh, Mina
author_sort Boostani, Reza
collection PubMed
description Background: Guillain-Barre syndrome (GBS) is the major cause of acute flaccid paralysis (AFP). Comprehensive classification and predictive measures need to be created for GBS. This study was conducted to evaluate GBS patients’ prognosis and Brighton criteria validity in Iranian population. Methods: This retrospective cohort study was conducted using medical records of patients with GBS admitted to Ghaem Hospital, Mashhad, Iran. After collecting data from cerebrospinal fluid (CSF) analysis, nerve conduction studies, and clinical examinations, Brighton criteria and GBS disability scores were calculated. Patients ultimately received follow-up telephone calls after 15 to 45 months of admission, checking on one’s clinical status and the ability to walk independently. Data were analyzed using SPSS software. Results: Patients were mostly men (78.0%) with the mean age of 48.58 years. GBS onset was reported more frequently in spring. According to Brighton criteria, 41.4%, 51.6%, and 7.0% of the patients were classified as levels 1, 2, and 4, respectively. For GBS disability score, 54.7%, 16.4%, 9.4%, and 6.2% of the patients had grades of 4, 3, 2, and 1, respectively. 37 patients (39.4%) restored the ability to walk within the first month, while 3 patients (3.2%) were unable to walk by the end of the second year. Significant relationship was observed between the ability of walking independently and GBS disability score (P < 0.001). Conclusion: In the Iranian GBS population, less than half of the patients met level 1 of Brighton criteria and more than half of them reached the GBS disability score of 4, and walking ability was correlated to GBS disability score.
format Online
Article
Text
id pubmed-6755501
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Tehran University of Medical Sciences
record_format MEDLINE/PubMed
spelling pubmed-67555012019-09-27 A follow-up study on Guillain-Barre syndrome and validation of Brighton criteria Boostani, Reza Ramezanzadeh, Farveh Saeidi, Morteza Khodabandeh, Mina Iran J Neurol Original Article Background: Guillain-Barre syndrome (GBS) is the major cause of acute flaccid paralysis (AFP). Comprehensive classification and predictive measures need to be created for GBS. This study was conducted to evaluate GBS patients’ prognosis and Brighton criteria validity in Iranian population. Methods: This retrospective cohort study was conducted using medical records of patients with GBS admitted to Ghaem Hospital, Mashhad, Iran. After collecting data from cerebrospinal fluid (CSF) analysis, nerve conduction studies, and clinical examinations, Brighton criteria and GBS disability scores were calculated. Patients ultimately received follow-up telephone calls after 15 to 45 months of admission, checking on one’s clinical status and the ability to walk independently. Data were analyzed using SPSS software. Results: Patients were mostly men (78.0%) with the mean age of 48.58 years. GBS onset was reported more frequently in spring. According to Brighton criteria, 41.4%, 51.6%, and 7.0% of the patients were classified as levels 1, 2, and 4, respectively. For GBS disability score, 54.7%, 16.4%, 9.4%, and 6.2% of the patients had grades of 4, 3, 2, and 1, respectively. 37 patients (39.4%) restored the ability to walk within the first month, while 3 patients (3.2%) were unable to walk by the end of the second year. Significant relationship was observed between the ability of walking independently and GBS disability score (P < 0.001). Conclusion: In the Iranian GBS population, less than half of the patients met level 1 of Brighton criteria and more than half of them reached the GBS disability score of 4, and walking ability was correlated to GBS disability score. Tehran University of Medical Sciences 2019-04-04 /pmc/articles/PMC6755501/ /pubmed/31565202 Text en Copyright © 2015 Iranian Neurological Association, and Tehran University of Medical Sciences This is an Open Access article distributed under the terms of the Creative Commons Attribution License, (http://creativecommons.org/licenses/by/3.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Boostani, Reza
Ramezanzadeh, Farveh
Saeidi, Morteza
Khodabandeh, Mina
A follow-up study on Guillain-Barre syndrome and validation of Brighton criteria
title A follow-up study on Guillain-Barre syndrome and validation of Brighton criteria
title_full A follow-up study on Guillain-Barre syndrome and validation of Brighton criteria
title_fullStr A follow-up study on Guillain-Barre syndrome and validation of Brighton criteria
title_full_unstemmed A follow-up study on Guillain-Barre syndrome and validation of Brighton criteria
title_short A follow-up study on Guillain-Barre syndrome and validation of Brighton criteria
title_sort follow-up study on guillain-barre syndrome and validation of brighton criteria
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6755501/
https://www.ncbi.nlm.nih.gov/pubmed/31565202
work_keys_str_mv AT boostanireza afollowupstudyonguillainbarresyndromeandvalidationofbrightoncriteria
AT ramezanzadehfarveh afollowupstudyonguillainbarresyndromeandvalidationofbrightoncriteria
AT saeidimorteza afollowupstudyonguillainbarresyndromeandvalidationofbrightoncriteria
AT khodabandehmina afollowupstudyonguillainbarresyndromeandvalidationofbrightoncriteria
AT boostanireza followupstudyonguillainbarresyndromeandvalidationofbrightoncriteria
AT ramezanzadehfarveh followupstudyonguillainbarresyndromeandvalidationofbrightoncriteria
AT saeidimorteza followupstudyonguillainbarresyndromeandvalidationofbrightoncriteria
AT khodabandehmina followupstudyonguillainbarresyndromeandvalidationofbrightoncriteria